Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

140.29 -3.37 (-2.34%)
Streaming Delayed Price Updated: 12:14 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 278,508
Open 142.48
Bid (Size) 140.20 (2)
Ask (Size) 140.50 (2)
Prev. Close 143.66
Today's Range 139.83 - 143.02
52wk Range 117.08 - 189.07
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths. 
Via Benzinga
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
The FDA's experts voted in favor of annual boosters on Thursday. 
Via Investor's Business Daily

Performance

YTD
-5.62%
-5.62%
1 Month
-6.61%
-6.61%
3 Month
+1.93%
+1.93%
6 Month
-14.18%
-14.18%
1 Year
-18.47%
-18.47%

More News

Read More
Mergers and Acquisitions in 2023 Off To A Strong Start
Via MarketBeat
Exposures Product Safety
Thursday Predictions: 3 Hot Stocks for Tomorrow
Via InvestorPlace
Analyst Ratings for BioNTech
Via Benzinga
COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today
Via Benzinga
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
Via Benzinga
Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots
Via Benzinga
Pfizer (PFE) Stock Falls on Analyst Downgrade
Via InvestorPlace
Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades Shares
Via Investor's Business Daily
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People
Via Benzinga
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
Via Benzinga
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing”
Via Talk Markets
BioNTech Strengthens Its Artificial Intelligence With Acquisition Of British Startup
Via Benzinga
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
From BioNTech SE
Via Globe NewsWire
Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly
Via Benzinga
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
Via Investor's Business Daily
2 Top Biotech Stocks to Buy Right Now
Via The Motley Fool
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030
From BioNTech SE
Via Globe NewsWire
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
Via Benzinga
Why BioNTech Was a Sickly Stock This Week
Via The Motley Fool
BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference
From BioNTech SE
Via Globe NewsWire
Three Pharma Stocks to Sell Before They Die
Via InvestorPlace
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
From BioNTech SE
Via Globe NewsWire
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
From BioNTech SE
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.